| 000 | 02597 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250516073110.0 | ||
| 264 | 0 | _c20120612 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1873-2399 | ||
| 024 | 7 |
_a10.1016/j.exphem.2012.01.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAiriau, Kelly | |
| 245 | 0 | 0 |
_aABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib. _h[electronic resource] |
| 260 |
_bExperimental hematology _cMay 2012 |
||
| 300 |
_a367-78.e2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, CD34 _xanalysis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xphysiology |
| 650 | 0 | 4 | _aBcl-2-Like Protein 11 |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHigh-Temperature Requirement A Serine Peptidase 2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aK562 Cells _xdrug effects |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xpathology |
| 650 | 0 | 4 |
_aMembrane Proteins _xphysiology |
| 650 | 0 | 4 |
_aMitochondrial Proteins _xphysiology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aNitrophenols _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xphysiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xphysiology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xbiosynthesis |
| 700 | 1 | _aMahon, François-Xavier | |
| 700 | 1 | _aJosselin, Marina | |
| 700 | 1 | _aJeanneteau, Marie | |
| 700 | 1 | _aTurcq, Beatrice | |
| 700 | 1 | _aBelloc, Francis | |
| 773 | 0 |
_tExperimental hematology _gvol. 40 _gno. 5 _gp. 367-78.e2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exphem.2012.01.004 _zAvailable from publisher's website |
| 999 |
_c21456952 _d21456952 |
||